News tagged with drug manufacturers
Related topics: centers for disease control and prevention , food and drug administration , health officials , drug
Renaissance in new drugs for rare diseases
Once famously described as "orphan diseases, too small to be noticed, too small to be funded" in the Hollywood drama Lorenzo's Oil, rare diseases are getting unprecedented attention today among drug manufacturers, ...
Medications
May 13, 2013 |
not rated yet |
0
Health industry payment details to be publicly available
(HealthDay)—As part of the National Physician Payment Transparency Program and in compliance with a provision in the Affordable Care Act (ACA), the government will make information about financial relationships ...
Health
May 02, 2013 |
5 / 5 (1) |
0
FDA rejects two HIV drugs from Gilead Sciences
Gilead Sciences Inc. says that the Food and Drug Administration rejected two marketing applications for HIV treatments, citing quality control problems at the company's manufacturing facilities.
Medications
Apr 29, 2013 |
1 / 5 (1) |
0
Potential diabetes breakthrough: Researchers discover new hormone spurring beta cell production
Researchers at the Harvard Stem Cell Institute (HSCI) have discovered a hormone that holds promise for a dramatically more effective treatment of type 2 diabetes, a metabolic illness afflicting an estimated ...
Medical research
Apr 25, 2013 |
4.9 / 5 (12) |
0
|
Fearing abuse, US blocks generic OxyContin (Update)
U.S. health regulators will require generic versions of the best-selling painkiller OxyContin to include recent formulation changes designed to make the pill harder to abuse.
Medications
Apr 16, 2013 |
not rated yet |
1
Mining information contained in clinical notes could yield early signs of harmful drug reactions
Mining the records of routine interactions between patients and their care providers can detect drug side effects a couple of years before an official alert from the U.S. Food and Drug Administration, a Stanford University ...
Medications
Apr 10, 2013 |
not rated yet |
0
|
Misuse of drug patenting could cost the health system billions
(Medical Xpress)—Companies may be misusing the drug patenting system in order to gain control over high-cost drugs in Australia, research from the Melbourne Law School has found.
Medications
Apr 10, 2013 |
5 / 5 (1) |
0
|
Drug maker Novartis loses India patent battle (Update)
India's Supreme Court on Monday rejected drug maker Novartis AG's attempt to patent an updated version of a cancer drug in a landmark decision that health activists say ensures poor patients around the world ...
Medications
Apr 01, 2013 |
5 / 5 (3) |
0
Lung-on-a-Chip wins prize for potentially reducing need for animal testing
In a London ceremony today, Wyss Founding Director Don Ingber, M.D., Ph.D., received the NC3Rs 3Rs Prize from the UK's National Centre for the Replacement, Refinement and Reduction of Animals in Research ...
Medical research
Feb 26, 2013 |
not rated yet |
0
Analysis finds vitamin D potency varies widely in dietary supplements
Vitamin D supplement potency varies widely, and the amount of vitamin D in over-the counter and compounded supplements does not necessarily match the amount listed on the label, according to a research letter published in ...
Health
Feb 11, 2013 |
5 / 5 (2) |
1
Novo Nordisk US shares skid on drug review setback (Update)
Shares of Novo Nordisk tumbled Monday after the Danish drugmaker said U.S. regulators need a new study before they can finish their review of two diabetes treatments, a development that could delay approval for several years.
Other
Feb 11, 2013 |
not rated yet |
0
Bevacizumab significantly improves survival for patients with recurrent and metastatic cervical cancer
(Medical Xpress)—Patients with advanced, recurrent, or persistent cervical cancer that was not curable with standard treatment who received the drug bevacizumab (Avastin) lived 3.7 months longer than patients who did not ...
Cancer
Feb 08, 2013 |
not rated yet |
0
Added benefit of aclidinium bromide is not proven
The drug aclidinium bromide (trade names Eklira, Bretaris) has been approved since October 2012 for widening the narrowed airways of adults with chronic-obstructive pulmonary disease (COPD). The German Institute for Quality ...
Medications
Jan 30, 2013 |
not rated yet |
0
FDA requires lower doses for sleep medications (Update)
(HealthDay)—The U.S. Food and Drug Administration announced Thursday that it is asking manufacturers of sleep medications containing zolpidem—including Ambien—to lower the recommended doses and to provide ...
Medications
Jan 10, 2013 |
not rated yet |
0
US proposes sweeping new food safety rules (Update)
The U.S. Food and Drug Administration on Friday proposed the most sweeping food safety rules in decades, requiring farmers and food companies to be more vigilant in the wake of deadly outbreaks in peanuts, cantaloupe and ...
Health
Jan 04, 2013 |
not rated yet |
1
